Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review.
Phillips KA, Veenstra DL, Oren E, et al. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA. 2001;286(18):2270-9.
This study suggests that utilizing a patient’s genetic information to individualize medication treatments can help reduce adverse drug reactions.